Read our COVID-19 research and news.

Webinar Science and Life

Coronavirus: A survival guide

This webinar is brought to you by the Science/AAAS Custom Publishing Office

Coronavirus: A survival guide

Recorded 16 April 2020


The coronavirus outbreak has made us completely change our modern behaviors. We are reinventing family relationships, work practices, exercise regimens, and socialization. This webinar uses the best scientific advice to guide you into this new life. We will examine the current conditions in which we find ourselves, putting our fears into context. We’ll discuss how to adapt to the new normal: spending more time with family, altered personal freedom, and potential changes in our jobs. How can we become more mentally resilient? What will things look like on the other side of the infection peak, biologically and psychologically?

Our world has changed dramatically. There is a growing appreciation for the value of science. Lean on us to learn how best to cope and to rise to the challenge of a new reality.

This webinar will last for approximately 90 minutes.

Speaker bios

Laurie Santos, Ph.D.

Yale University
New Haven, CT

Dr. Laurie Santos is professor of psychology and head of Silliman College at Yale University. She is an expert on human cognition and the cognitive biases that impede better choices. Her course, Psychology and the Good Life, teaches students how the science of psychology can provide important hints about how to make wiser choices and live a life that’s happier and more fulfilling. It recently became Yale’s most popular course in over 300 years, with almost one out of four Yale students enrolled. Her course has been featured in numerous news outlets, including The New York Times, NBC Nightly News, the Today Show, GQ Magazine, Slate, and O, The Oprah Magazine. A winner of numerous awards both for her science and teaching, she was recently voted as one of Popular Science magazine’s “Brilliant 10” young minds and was named in Time as a “leading campus celebrity.” She hosts a new podcast called The Happiness Lab with Pushkin Industries.

Arnaud Fontanet, M.D., Dr.P.H.

Institut Pasteur
Paris, France

Dr. Fontanet is a medical epidemiologist with an M.D. from Paris V and Dr.P.H. from the Harvard School of Public Health, specialized in infectious diseases epidemiology. After working at the World Health Organization at the clinical research unit of the Global Program on AIDS from 1993 to 1994), he spent five years in Ethiopia and two years in the Netherlands working as the Program Manager of the Ethio-Netherlands AIDS Research Project (1994-2001). In 2002, he joined Institut Pasteur in Paris, France to launch the Emerging Diseases Epidemiology unit. There, his focus has been on viral hepatitis C (North-Coordinator of the ANRS research site on viral hepatitis; and emerging infections such as the SARS (scientific coordinator of the EPISARS project that aimed to prevent the re-emergence of SARS through the control of its animal reservoir) and the MERS-CoV. Dr. Fontanet is also codirector and founder of the Pasteur-Cnam School of Public Health, and coordinator of a Master’s program in public health with strong focus on infectious diseases. In 2014, he was appointed director of the newly created Pasteur Centre for Global Health Research and Education.

Marc Lipsitch, Ph.D.

Harvard University
Boston, MA

Dr. Lipsitch is professor of epidemiology with a primary appointment in the Department of Epidemiology at the Harvard University T. H. Chan School of Public Health and a joint appointment in the Department of Immunology and Infectious Diseases, where his wet lab is located. He directs the Center for Communicable Disease Dynamics, a center of excellence funded by the MIDAS (Models of Infectious Disease Agent Study) program of the National Institute of General Medical Sciences at the U.S. National Institutes of Health in Bethesda, Maryland. He is also the associate director of the Interdisciplinary Concentration in Infectious Disease Epidemiology at Harvard. His research concerns the effect of naturally acquired host immunity, vaccine-induced immunity, and other public health interventions (for example, antimicrobial use) on the population biology of pathogens and the consequences of changing pathogen populations for human health. This work is motivated partially by practical questions in public health—such as vaccine design and intervention targeting—and partially by classical questions in population biology, such as how to explain patterns of coexistence of pathogen strains in space and time. He is an author of more than 250 peer-reviewed publications on antimicrobial resistance, epidemiologic methods, mathematical modeling of infectious disease transmission, pathogen population genomics, and immunoepidemiology of Streptococcus pneumoniae. Dr. Lipsitch is a prominent voice in the novel coronavirus (SARS-CoV-2) research community and is frequently interviewed by and published in the news media.

Holden Thorp, Ph.D.

Washington, DC

Dr. Thorp became Editor-in-Chief of the Science family of journals on 28 October 2019. He came to Science from Washington University, where he was provost from 2013 to 2019 and where he is Rita Levi-Montalcini Distinguished University Professor and holds appointments in both chemistry and medicine. He joined Washington University after spending three decades at the University of North Carolina at Chapel Hill (UNC), wherehe served as the 10th chancellor from 2008 through 2013.

A North Carolina native, Dr. Thorp started at UNC as an undergraduate student and earned a bachelor of science degree in chemistry with highest honors in 1986. He earned a doctorate in chemistry in 1989 at the California Institute of Technology, working with Harry B. Gray on inorganic photochemistry. He completed postdoctoral work at Yale University with Gary W. Brudvig, working on model compounds and reactions for the manganese cluster in the photosynthetic reaction center. He holds an honorary doctor of laws degree from North Carolina Wesleyan College and is a fellow of the National Academy of Inventors.

In his research career, he studied electron-transfer reactions of nucleic acids, developed technology for electronic DNA chips, and cofounded Viamet Pharmaceuticals, which developed oteseconazole, now held by Mycovia Pharmaceuticals and in phase 3 clinical trials. He is a venture partner at Hatteras Venture Partners, a consultant to Ancora, and is on the board of directors of the College Advising Corps and Artizan Biosciences.

Dr. Thorp is the coauthor, with Buck Goldstein, of two books on higher education: Engines of Innovation: The Entrepreneurial University in the Twenty-First Century and Our Higher Calling: Rebuilding the Partnership Between America and its Colleges and Universities, both from UNC Press.

Sean Sanders, Ph.D.

Washington, DC

Dr. Sanders did his undergraduate training at the University of Cape Town, South Africa, and his Ph.D. at the University of Cambridge, UK, supported by the Wellcome Trust. Following postdoctoral training at the National Institutes of Health and Georgetown University, Dr. Sanders joined TranXenoGen, a startup biotechnology company in Massachusetts working on avian transgenics. Pursuing his parallel passion for writing and editing, Dr. Sanders joined BioTechniques as an editor, before joining Science/AAAS in 2006. Currently, Dr. Sanders is the Director and Senior Editor for Custom Publishing for the journal Science and Program Director for Outreach.

Sponsored by

Get webinar alerts

For more information on upcoming webinars, recorded sessions and more, sign up for webinar alerts.

Sign up here